Pharmaceuticals and Biotech Press Releases

Seasoned Healthcare Executive Michael Raymer Joins Pro-ficiency as CEO

Seasoned Healthcare Executive Michael Raymer Joins Pro-ficiency as CEO

Pro-ficiency, the leading provider of simulation-enabled, experiential training for clinical research, is excited to announce the appointment of Michael Raymer to the position of Chief Executive Officer. Raymer joins Pro-ficiency with over 25 years of executive experience in the development of…

Glauconix Biosciences Expands Scientific Advisory Board for 3D Human Tissue Retina Vasculature Model With the Addition of Leading Expert Dr. Patricia D’Amore

Glauconix Biosciences Expands Scientific Advisory Board for 3D Human Tissue Retina Vasculature Model With the Addition of Leading Expert Dr. Patricia D’Amore

Glauconix Biosciences, Inc., a specialty pharmaceutical company that uses its patented platform technology to develop human 3D tissues to expedite and de-risk the R&D of therapeutic treatments, announced today the launch of their Scientific Advisory Board with the appointment of…

Canada Drugs Direct: Order Rx Meds From Canada to Avoid 2x Higher Prescription Drugs Prices in U.S.

Canada Drugs Direct: Order Rx Meds From Canada to Avoid 2x Higher Prescription Drugs Prices in U.S.

The continual rise of prescription drug costs in America sees the average person spend around $1200 per year, more than any other country in the world. It creates struggles for Americans who can't afford their medications. To help alleviate the…

Enterin to Present at Chardan’s Virtual 3rd Annual Microbiome Medicines Summit

Enterin to Present at Chardan’s Virtual 3rd Annual Microbiome Medicines Summit

Enterin, Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative diseases, announces that the company will be presenting at Chardan's virtual 3rd Annual Microbiome Medicines Summit on March 8, 2021, at 8:30 a.m. ET.Dr. Denise Barbut, Enterin's…

Enterin Announces Appointment of Chief Financial Officer

Enterin Announces Appointment of Chief Financial Officer

Enterin, Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative diseases, announces the appointment of Katherine Wolf as Chief Financial Officer. Ms. Wolf brings 30 years of health care industry experience in capital raising, business development, and strategy,…

Inherent Biosciences Raises Seed Round, Adds Board Members and Clinical Advisors

Inherent Biosciences Raises Seed Round, Adds Board Members and Clinical Advisors

Inherent Biosciences today announced its initial capital raise led by Morning Star Foundation with additional participation from MedMountain Ventures, Kickstart Funds, Park City Angels, Rhythm VC and several angel investors. With the initial funding, Inherent will launch a male infertility…

NephroSant Announces Mark Capone as Independent Board Member

NephroSant Announces Mark Capone as Independent Board Member

NephroSant, a Kidney Health spin out of UCSF, today announced that Mark Capone has officially joined the Board of Directors. Following the appointment of Mr. Capone, the Board will comprise 7 directors, 2 of whom are independent."We are thrilled to…

RxCelerate Launch Galaxy™: A Next-Generation Antibody Discovery Platform

RxCelerate Launch Galaxy™: A Next-Generation Antibody Discovery Platform

RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new antibody discovery platform, Galaxy™, that offers significant advantages over the current generation of tools for delivery of new therapeutic monoclonal antibodies."Monoclonal antibodies make up…

Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease

Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease

Avexegen Therapeutics Inc. today announced that it has received a Phase 2 award of $2.94 million under the National Institutes of Health's Small Business Innovation Research Program (SBIR) for the development of an oral Neuregulin-4-based therapy for inflammatory bowel disease…

Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of Krabbe Disease With PLX-300

Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of Krabbe Disease With PLX-300

Polaryx Therapeutics, Inc., a biotech company developing small molecule therapeutics for lysosomal storage disorders, announced today that it has received both Rare Pediatric Disease and Orphan Drug Designations for the treatment of Krabbe Disease (a.k.a. Globoid Cell Leukodystrophy) with PLX-300 from the U.S. Food and…

Native Cardio to Present at the Georgetown and Maryland PNP University Pitch Session

Native Cardio to Present at the Georgetown and Maryland PNP University Pitch Session

Native Cardio, Inc., a cardiac medical device manufacturer located in Naples, Florida, dedicated to developing medical devices to improve the outcomes of patients suffering from acute and chronic atrial fibrillation, announced today that Joe Pergolizzi, M.D., President and Chief Executive…

Inova Appoints Claude Basset as Chief Product Officer

Inova Appoints Claude Basset as Chief Product Officer

Inova, the market-leading partnering platform for the pharmaceutical and biotech industry, today announced that Claude Basset has joined their leadership team as Chief Product Officer.  Inova is a French Tech success story that, now in its 10th year, has captured more than half of the partnering…

Akelos Inc.’s SAB Member Co-Authors Paper Validating HCN1 as a Therapeutic Target for the Treatment of Peripheral Neuropathic Pain

Akelos Inc.’s SAB Member Co-Authors Paper Validating HCN1 as a Therapeutic Target for the Treatment of Peripheral Neuropathic Pain

Dr. Peter Goldstein, scientific co-founder of Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, has just co-authored a review article in the peer-reviewed journal Current Neuropharmacology (doi: 10.2174/1570159X19666210119153047.…

Peak Serum, Inc. Appoints Interim CEO

Peak Serum, Inc. Appoints Interim CEO

Effectively immediately, Thomas Kutrubes has been removed from privately owned and independent supplier of life science laboratory products — Peak Serum, Inc. (Peak) — by the chief restructuring officer and Trustee, Jay Roderick. Michael Dodge, Peak's current global director of…

Enalare Therapeutics Announces Closing of Successful Seed Funding Round

Enalare Therapeutics Announces Closing of Successful Seed Funding Round

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for life-threatening acute respiratory and critical care conditions, announced today that it has successfully closed its seed funding round of $10 million. The offering was met with significant…

BIOXO SOLUTIONS LLC is looking for Venture Capital to move this revolutionary company forward

BIOXO SOLUTIONS LLC is looking for Venture Capital to move this revolutionary company forward

Nichol brings years of experience and entrepreneurial success. Nichol is a mother of 3 amazing kids and a widow to her loving late husband of 25 years. At the age of 21 Nichol created her first company with 50 employees.…

BenchSci Listed as Best Workplace™ for Startups in Canada for 2nd Consecutive Year

BenchSci Listed as Best Workplace™ for Startups in Canada for 2nd Consecutive Year

BenchSci has been listed as a Best Workplace™ for Startups for the second consecutive year. This honor follows thorough and independent analysis by Great Place to Work® Institute Canada.BenchSci's mission is to increase the speed and quality of life-saving research.…

Notable Labs to Present Analysis of Hematologic Oncology Drug Sensitivity Data

Notable Labs to Present Analysis of Hematologic Oncology Drug Sensitivity Data

Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced that it is hosting a live webinar on February 9 to unveil their integrative data platform. The Notable data scientists will share…

Sentry Data Systems Earn Top Client Satisfaction Ratings in 340B Management Systems, Black Book Survey

Sentry Data Systems Earn Top Client Satisfaction Ratings in 340B Management Systems, Black Book Survey

Black Book Research announced that Sentry Data Systems achieved the top honor for highest user experience and outcomes in the annual customer polling of top 340B solutions' customers. Black Book's intensive study of 340B management systems included the input of pharmacy and…

Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area

Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony on Jan. 20, 2021, the opening of its new…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login